ATE108659T1 - Verfahren zur reinigung von rückständigen tumorzellen in vitro mit lymphokinaktivierten zytotoxischen zellen. - Google Patents

Verfahren zur reinigung von rückständigen tumorzellen in vitro mit lymphokinaktivierten zytotoxischen zellen.

Info

Publication number
ATE108659T1
ATE108659T1 AT88310432T AT88310432T ATE108659T1 AT E108659 T1 ATE108659 T1 AT E108659T1 AT 88310432 T AT88310432 T AT 88310432T AT 88310432 T AT88310432 T AT 88310432T AT E108659 T1 ATE108659 T1 AT E108659T1
Authority
AT
Austria
Prior art keywords
cells
lymphokine
vitro
inactivated
purification
Prior art date
Application number
AT88310432T
Other languages
English (en)
Inventor
Joseph H Phillips
Arnon Nagler
Lewis L Lanier
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE108659T1 publication Critical patent/ATE108659T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88310432T 1987-11-13 1988-11-07 Verfahren zur reinigung von rückständigen tumorzellen in vitro mit lymphokinaktivierten zytotoxischen zellen. ATE108659T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/120,299 US5041289A (en) 1987-11-13 1987-11-13 Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells

Publications (1)

Publication Number Publication Date
ATE108659T1 true ATE108659T1 (de) 1994-08-15

Family

ID=22389429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88310432T ATE108659T1 (de) 1987-11-13 1988-11-07 Verfahren zur reinigung von rückständigen tumorzellen in vitro mit lymphokinaktivierten zytotoxischen zellen.

Country Status (6)

Country Link
US (1) US5041289A (de)
EP (1) EP0317141B1 (de)
JP (1) JPH022345A (de)
AT (1) ATE108659T1 (de)
DE (1) DE3850745T2 (de)
ES (1) ES2059537T3 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0494268T4 (da) * 1989-09-25 1999-11-08 Genetics Inst Fremgangsmåde til inhibering af stamcellers vækst
US5728388A (en) * 1989-10-03 1998-03-17 Terman; David S. Method of cancer treatment
US5229115A (en) * 1990-07-26 1993-07-20 Immunex Corporation Adoptive immunotherapy with interleukin-7
US5814295A (en) * 1992-04-10 1998-09-29 The Ohio State University Research Foundation Determination of lymph nodes enriched in tumor reactive cells their proliferation and their use in adoptive cellular therapy
CA2157379A1 (en) * 1993-03-02 1994-09-15 David S. Terman Method of cancer treatment
US6093381A (en) * 1994-07-13 2000-07-25 Neoprobe Corporation Modulation of the sensitivity of tumor cells to chemotherapeutics
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CN1195851C (zh) 1997-02-25 2005-04-06 科里克萨有限公司 用于前列腺癌免疫疗法的化合物及其用途
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6623923B1 (en) 1998-12-23 2003-09-23 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
KR20010083111A (ko) * 1998-07-14 2001-08-31 길리스 스티브 전립선암의 치료 및 진단을 위한 조성물 및 방법
WO2001025272A2 (en) * 1999-10-04 2001-04-12 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
CA2391369A1 (en) * 1999-11-12 2001-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
WO2001049716A2 (en) * 1999-12-30 2001-07-12 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US4604377A (en) * 1984-03-28 1986-08-05 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans

Also Published As

Publication number Publication date
DE3850745T2 (de) 1994-11-24
EP0317141A3 (en) 1990-04-04
ES2059537T3 (es) 1994-11-16
EP0317141B1 (de) 1994-07-20
JPH022345A (ja) 1990-01-08
US5041289A (en) 1991-08-20
DE3850745D1 (de) 1994-08-25
EP0317141A2 (de) 1989-05-24

Similar Documents

Publication Publication Date Title
ATE108659T1 (de) Verfahren zur reinigung von rückständigen tumorzellen in vitro mit lymphokinaktivierten zytotoxischen zellen.
DE3855921D1 (de) Verfahren und Desoxyribonukleinsäure zur Herstellung von Gewebefaktor-Protein
ATE88987T1 (de) Verfahren und vorrichtung zur reinigung von wasser mittels polypyrrolidon.
ATA160487A (de) Verfahren zur herstellung eines transdermalen therapeutischen membransystems mit diclofenac
DE3770190D1 (de) Beleuchtungsanordnung fuer ein system zur behandlung eines patienten durch photoaktivierung.
ATE113618T1 (de) Verfahren zur herstellung von polybutenen mit verbesserter reaktionsfähigkeit mittels bortrifluorid-katalysatoren.
DE69033068D1 (de) Verfahren zur Herstellung von Methacrolein und Methacrylsäure
ATE159545T1 (de) Vorläufer b-zelle stimulierender faktor
DE3878627D1 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DE68926491D1 (de) Verfahren zur Hestellung von Polyetherpolyolen mit verminderter Ungesättigtheit
DE68926417D1 (de) Verfahren zur herstellung von optisch aktiven 2-hydroxysäureabkömmlingen
DE3878075D1 (de) Verfahren zur reinigung des plazentaren gewebeproteins pp4.
ATE81495T1 (de) Verfahren zur herstellung von natriumfluoralkoholaten.
ATE92056T1 (de) Verfahren zur herstellung von 5-chlor-3chlorsulfonyl-2-thiophencarbonsaeureestern.
DE3773716D1 (de) Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
ATA32078A (de) Verfahren zur herstellung von neuen amino-spiro (oxa(oder thia)-cycloalkanpenam) carbonsaeuren sowie von deren salzen und estern
DE3576163D1 (de) Absorbierendes polymeres material und dessen herstellung.
DE3884261D1 (de) Verfahren zur Herstellung von Fremdproteinen in Streptomyceten.
ATE6639T1 (de) Ein gereinigtes polypeptid, ein verfahren zu dessen herstellung, dessen anwendung und das enthaltende pharmazeutische praeparat.
DE3689562D1 (de) Verfahren zur Erzeugung des menschlichen Wachstumhormons.
DK118186D0 (da) Apparat til automatisk orientering af fisk i forhold til en fiskebehandlingstransportoer
ATE73125T1 (de) Verfahren zur herstellung von dialkylaminoethylaminen.
DE3851942D1 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.
DE3887376D1 (de) 2-Methyl-4-amino-5-aminomethylpyrimidinkarbonat, Verfahren zu dessen Herstellung und diese brauchende Methode zur Reinigung von 2-Methyl-4-amino-5-aminomethylpyrimidin.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee